Lixte Biotechnology (LIXT) Institutional Ownership $4.29 +0.14 (+3.37%) Closing price 04:00 PM EasternExtended Trading$4.29 0.00 (0.00%) As of 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lixte Biotechnology (NASDAQ:LIXT)CurrentInstitutional OwnershipPercentage5.10%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$314.53KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$65.81K Get LIXT Insider Trade Alerts Want to know when executives and insiders are buying or selling Lixte Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LIXT Institutional Buying and Selling by Quarter Lixte Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/17/2025FNY Investment Advisers LLC107,000$129K0.1%+172.8%3.396% 2/11/2025TIAA Trust National Association101,834$207K0.0%N/A4.526% 1/31/2025Atlas Legacy Advisors LLC12,707$26K0.0%N/A0.565% 1/13/2025FNY Investment Advisers LLC39,219$82K0.0%-45.3%1.744% 6/5/2023EP Wealth Advisors LLC2,211$786K0.0%N/A0.013% 2/9/2023Ethos Financial Group LLC248,084$126K0.0%N/A1.490% 8/12/2022Almanack Investment Partners LLC.248,084$185K0.0%-66.7%1.490% 11/9/2021BlackRock Inc.13,425$28K0.0%+191.9%0.098% 11/4/2021Almanack Investment Partners LLC.806,050$1.68M0.1%-17.9%5.863% 8/16/2021State Street Corp33,600$102K0.0%N/A0.244% 8/16/2021Sabby Management LLC65,511$199K0.0%-17.8%0.477% 8/13/2021Renaissance Technologies LLC50,900$154K0.0%N/A0.370% 8/13/2021Vanguard Group Inc.74,383$225K0.0%N/A0.544% 8/4/2021Almanack Investment Partners LLC.982,046$2.98M0.3%-5.8%7.189% 5/21/2021Citadel Advisors LLC23,813$79K0.0%N/A0.174% 5/18/2021Citadel Advisors LLC23,813$79K0.0%N/A0.174% (Data available from 1/1/2016 forward) LIXT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LIXT shares? During the previous two years, the following institutional investors and hedge funds held shares of Lixte Biotechnology shares: TIAA Trust National Association ($207K), and FNY Investment Advisers LLC ($129K), Atlas Legacy Advisors LLC ($26K).Learn more on Lixte Biotechnology's institutional investors. What percentage of Lixte Biotechnology's stock is owned by institutional investors? 5.10% of Lixte Biotechnology's stock is owned by institutional investors. Learn more on LIXT's institutional investor holdings. Which institutional investors have been buying Lixte Biotechnology's stock? The following institutional investors have purchased Lixte Biotechnology's stock in the last 24 months: TIAA Trust National Association ($101.83K), FNY Investment Advisers LLC ($67.78K), and Atlas Legacy Advisors LLC ($12.71K). How much institutional buying is happening at Lixte Biotechnology? Institutional investors have bought a total of 182,322 shares in the last 24 months. This purchase volume represents approximately $314.53K in transactions. Which of Lixte Biotechnology's major shareholders have been selling company stock? The following institutional investors have sold Lixte Biotechnology stock in the last 24 months: FNY Investment Advisers LLC ($32.42K). How much institutional selling is happening at Lixte Biotechnology? Institutional investors have sold a total of 32,419 shares in the last 24 months. This volume of shares sold represents approximately $65.81K in transactions. Related Companies TELO Major Shareholders HYPD Major Shareholders OKUR Major Shareholders KZR Major Shareholders CALC Major Shareholders ESLA Major Shareholders SCYX Major Shareholders SNYR Major Shareholders FGEN Major Shareholders CLNN Major Shareholders This page (NASDAQ:LIXT) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
